[{"id":"1c2892ea-1261-4dae-afe1-c46131b3f056","acronym":"","url":"https://clinicaltrials.gov/study/NCT07039760","created_at":"2025-06-28T13:40:51.525Z","updated_at":"2025-06-28T13:40:51.525Z","phase":"Phase 1","brief_title":"Asciminib With or Without Sildenafil for Brain Tumors","source_id_and_acronym":"NCT07039760","lead_sponsor":"Washington University School of Medicine","biomarkers":" CRKL • ABL2","pipe":"","alterations":" ","tags":["CRKL • ABL2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Scemblix (asciminib) • sildenafil"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 12","initiation":"Initiation: 12/01/2025","start_date":" 12/01/2025","primary_txt":" Primary completion: 06/01/2027","primary_completion_date":" 06/01/2027","study_txt":" Completion: 06/01/2027","study_completion_date":" 06/01/2027","last_update_posted":"2025-06-26"},{"id":"dd5c1528-650e-4f86-af1b-46bb0c06786d","acronym":"","url":"https://clinicaltrials.gov/study/NCT01496573","created_at":"2021-01-18T06:16:17.944Z","updated_at":"2024-07-02T16:37:31.970Z","phase":"","brief_title":"Biomarkers in Tumor Tissue Samples From Younger Patients With Rhabdomyosarcoma","source_id_and_acronym":"NCT01496573","lead_sponsor":"Children's Oncology Group","biomarkers":" CRKL","pipe":"","alterations":" ","tags":["CRKL"],"overall_status":"Completed","enrollment":" Enrollment 77","initiation":"Initiation: 12/01/2011","start_date":" 12/01/2011","primary_txt":" Primary completion: 05/01/2016","primary_completion_date":" 05/01/2016","study_txt":" Completion: 05/01/2016","study_completion_date":" 05/01/2016","last_update_posted":"2016-05-19"}]